Factors associated with increased mortality in a predominantly HIV-infected population with Stevens Johnson syndrome and toxic epidermal necrolysis

PLoS ONE

Volumn 9, Issue 4, 2014, Pages

  Knight, Lauren ^a   Muloiwa, Rudzani ^b   Dlamini, Sipho ^b   Lehloenya, Rannakoe J ^b  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; COTRIMOXAZOLE; NEVIRAPINE; TUBERCULOSTATIC AGENT;

ADULT; ARTICLE; CLINICAL EVALUATION; COMORBIDITY; DISEASE ASSOCIATION; EPIDERMAL DETACHMENT; FEMALE; GRAM NEGATIVE BACTERIUM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SKIN CULTURE; SKIN DISEASE; STEVENS JOHNSON SYNDROME; SURVIVAL RATE; TOXIC EPIDERMAL NECROLYSIS; TUBERCULOSIS; COMPLICATION;

HIV INFECTIONS; HUMANS; STEVENS-JOHNSON SYNDROME;

EID: 84898869733     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0093543     Document Type: Article

References (15)

1. Fritsch PO, Sidoroff A (2000) Drug-induced Stevens-Johnson syndrome/toxic epidermal necrolysis. Am J Clin Dermatol. 1(6):349-60.
2. Coopman SA, Johnson RA, Platt R, Stern RS (1993) Cutaneous disease and drug reactions in HIV infection. N Engl J Med. 328(23):1670-4. (Pubitemid 23157349)
3. Roujeau JC (1997) Stevens-Johnson syndrome and toxic epidermal necrolysis are severity variants of the same disease which differs from erythema multiforme. J Dermatol. 24(11):726-9.
4. Inamadar AC, Palit A (2005) Acute skin failure: concept, causes, consequences and care. Indian J Dermatol Venereol Leprol. 71(6):379-85. (Pubitemid 41769419)
5. George SM, Harrison DA, Welch CA, Nolan KM, Friedmann PS (2008) Dermatological conditions in intensive care: a secondary analysis of the Intensive Care National Audit and Research Centre (ICNARC) Case Mix Programme database. Crit Care. 12 Suppl 1:S1.
6. Revuz J, Penso D, Roujeau JC, Guillaume JC, Payne CR, et al (1987) Toxic epidermal necrolysis. Clinical findings and prognosis factors in 87 patients. Arch Dermatol. 123(9):1160-5. (Pubitemid 17119309)
7. McGee T, Munster A (1998) Toxic epidermal necrolysis syndrome: mortality rate reduced with early referral to regional burn center, Plast Reconstr Surg. 102(4):1018-22. (Pubitemid 28414625)
8. de Prost N, Ingen-Housz-Oro S, Duong T, Valeyrie-Allanore L, Legrand P, et al. (2010) Bacteremia in Stevens-Johnson syndrome and toxic epidermal necrolysis: epidemiology, risk factors, and predictive value of skin cultures, Medicine (Baltimore) 89(1):28-36.
9. Struck MF, Hilbert P, Mockenhaupt M, Reichelt B, Steen M (2010) Severe cutaneous adverse reactions: emergency approach to non-burn epidermolytic syndromes, Intensive Care Med. 36(1):22-32.
10. Statistics South Africa (2011) Midyear population estimates. http://www.statssa.gov.za/publications/P0302/P03022011.pdf, Accessed 2012 November 9.
11. Horan TC, Andrus M, Dudeck MA (2008) CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting, Am J Infect Control. 36(5):309-32. (Pubitemid 351763841)
12. Montefour K, Frieden J, Hurst S, Helmich C, Headley D, et al. (2008) Acinetobacter baumannii: an emerging multidrug-resistant pathogen in critical care, Crit Care Nurse. 28(1):15-25; quiz 6.
13. Powell N, Munro JM, Rowbotham D (2006) Colonic involvement in Stevens-Johnson syndrome, Postgrad Med J. 82(968):e10.
14. Edell DS, Davidson JJ, Muelenaer AA, Majure M (1992) Unusual manifestation of Stevens-Johnson syndrome involving the respiratory and gastrointestinal tract, Pediatrics. 89(3):429-32.
15. Bastuji-Garin S, Fouchard N, Bertocchi M, Roujeau JC, Revuz J, et al. (2000) SCORTEN: a severity-of-illness score for toxic epidermal necrolysis, J Invest Dermatol. 115(2):149-53. (Pubitemid 30637181)